Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.

The role of phosphatidylcholine-specific phospholipase C (PC-PLC), the enzyme involved in cell differentiation and proliferation, has not yet been explored in tumor initiating cells (TICs). We investigated PC-PLC expression and effects of PC-PLC inhibition in two adherent (AD) squamous carcinoma cel...

Full description

Bibliographic Details
Main Authors: Serena Cecchetti, Ileana Bortolomai, Renata Ferri, Laura Mercurio, Silvana Canevari, Franca Podo, Silvia Miotti, Egidio Iorio
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4581859?pdf=render
_version_ 1828743810836856832
author Serena Cecchetti
Ileana Bortolomai
Renata Ferri
Laura Mercurio
Silvana Canevari
Franca Podo
Silvia Miotti
Egidio Iorio
author_facet Serena Cecchetti
Ileana Bortolomai
Renata Ferri
Laura Mercurio
Silvana Canevari
Franca Podo
Silvia Miotti
Egidio Iorio
author_sort Serena Cecchetti
collection DOAJ
description The role of phosphatidylcholine-specific phospholipase C (PC-PLC), the enzyme involved in cell differentiation and proliferation, has not yet been explored in tumor initiating cells (TICs). We investigated PC-PLC expression and effects of PC-PLC inhibition in two adherent (AD) squamous carcinoma cell lines (A431 and CaSki), with different proliferative and stemness potential, and in TIC-enriched floating spheres (SPH) originated from them.Compared with immortalized non-tumoral keratinocytes (HaCaT) A431-AD cells showed 2.5-fold higher PC-PLC activity, nuclear localization of a 66-kDa PC-PLC isoform, but a similar distribution of the enzyme on plasma membrane and in cytoplasmic compartments. Compared with A431-AD, A431-SPH cells showed about 2.8-fold lower PC-PLC protein and activity levels, but similar nuclear content. Exposure of adherent cells to the PC-PLC inhibitor D609 (48h) induced a 50% reduction of cell proliferation at doses comprised between 33 and 50 μg/ml, without inducing any relevant cytotoxic effect (cell viability 95±5%). In A431-SPH and CaSki-SPH D609 induced both cytostatic and cytotoxic effects at about 20 to 30-fold lower doses (IC50 ranging between 1.2 and 1.6 μg/ml). Furthermore, D609 treatment of A431-AD and CaSki-AD cells affected the sphere-forming efficiency, which dropped in both cells, and induced down-modulation of stem-related markers mRNA levels (Oct4, Nestin, Nanog and ALDH1 in A431; Nestin and ALDH1 in CaSki cells).These data suggest that the inhibition of PC-PLC activity may represent a new therapeutic approach to selectively target the most aggressive and tumor promoting sub-population of floating spheres originated from squamous cancer cells possessing different proliferative and stemness potential.
first_indexed 2024-04-13T01:44:28Z
format Article
id doaj.art-a5ce859f10134e8087303a739a35234b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T01:44:28Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a5ce859f10134e8087303a739a35234b2022-12-22T03:08:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013612010.1371/journal.pone.0136120Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.Serena CecchettiIleana BortolomaiRenata FerriLaura MercurioSilvana CanevariFranca PodoSilvia MiottiEgidio IorioThe role of phosphatidylcholine-specific phospholipase C (PC-PLC), the enzyme involved in cell differentiation and proliferation, has not yet been explored in tumor initiating cells (TICs). We investigated PC-PLC expression and effects of PC-PLC inhibition in two adherent (AD) squamous carcinoma cell lines (A431 and CaSki), with different proliferative and stemness potential, and in TIC-enriched floating spheres (SPH) originated from them.Compared with immortalized non-tumoral keratinocytes (HaCaT) A431-AD cells showed 2.5-fold higher PC-PLC activity, nuclear localization of a 66-kDa PC-PLC isoform, but a similar distribution of the enzyme on plasma membrane and in cytoplasmic compartments. Compared with A431-AD, A431-SPH cells showed about 2.8-fold lower PC-PLC protein and activity levels, but similar nuclear content. Exposure of adherent cells to the PC-PLC inhibitor D609 (48h) induced a 50% reduction of cell proliferation at doses comprised between 33 and 50 μg/ml, without inducing any relevant cytotoxic effect (cell viability 95±5%). In A431-SPH and CaSki-SPH D609 induced both cytostatic and cytotoxic effects at about 20 to 30-fold lower doses (IC50 ranging between 1.2 and 1.6 μg/ml). Furthermore, D609 treatment of A431-AD and CaSki-AD cells affected the sphere-forming efficiency, which dropped in both cells, and induced down-modulation of stem-related markers mRNA levels (Oct4, Nestin, Nanog and ALDH1 in A431; Nestin and ALDH1 in CaSki cells).These data suggest that the inhibition of PC-PLC activity may represent a new therapeutic approach to selectively target the most aggressive and tumor promoting sub-population of floating spheres originated from squamous cancer cells possessing different proliferative and stemness potential.http://europepmc.org/articles/PMC4581859?pdf=render
spellingShingle Serena Cecchetti
Ileana Bortolomai
Renata Ferri
Laura Mercurio
Silvana Canevari
Franca Podo
Silvia Miotti
Egidio Iorio
Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.
PLoS ONE
title Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.
title_full Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.
title_fullStr Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.
title_full_unstemmed Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.
title_short Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.
title_sort inhibition of phosphatidylcholine specific phospholipase c interferes with proliferation and survival of tumor initiating cells in squamous cell carcinoma
url http://europepmc.org/articles/PMC4581859?pdf=render
work_keys_str_mv AT serenacecchetti inhibitionofphosphatidylcholinespecificphospholipasecinterfereswithproliferationandsurvivaloftumorinitiatingcellsinsquamouscellcarcinoma
AT ileanabortolomai inhibitionofphosphatidylcholinespecificphospholipasecinterfereswithproliferationandsurvivaloftumorinitiatingcellsinsquamouscellcarcinoma
AT renataferri inhibitionofphosphatidylcholinespecificphospholipasecinterfereswithproliferationandsurvivaloftumorinitiatingcellsinsquamouscellcarcinoma
AT lauramercurio inhibitionofphosphatidylcholinespecificphospholipasecinterfereswithproliferationandsurvivaloftumorinitiatingcellsinsquamouscellcarcinoma
AT silvanacanevari inhibitionofphosphatidylcholinespecificphospholipasecinterfereswithproliferationandsurvivaloftumorinitiatingcellsinsquamouscellcarcinoma
AT francapodo inhibitionofphosphatidylcholinespecificphospholipasecinterfereswithproliferationandsurvivaloftumorinitiatingcellsinsquamouscellcarcinoma
AT silviamiotti inhibitionofphosphatidylcholinespecificphospholipasecinterfereswithproliferationandsurvivaloftumorinitiatingcellsinsquamouscellcarcinoma
AT egidioiorio inhibitionofphosphatidylcholinespecificphospholipasecinterfereswithproliferationandsurvivaloftumorinitiatingcellsinsquamouscellcarcinoma